SCHEMBL23360477

SCHEMBL23360477

CC(C)(C)OC(=O)N1CCC(Nc2ccnc3c(C(F)(F)F)cccc23)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
IDH1 O75874 1/20 0.47
IDH2 P48735 1/20 0.47
NPC1 O15118 1/20 0.47
MAPT P10636 1/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SYK P43405 1/20 0.46
PIM1 P11309 1/20 0.45
PIM2 Q9P1W9 1/20 0.45
GPR119 Q8TDV5 5/20 0.45
JAK1 P23458 1/20 0.45
HDAC4 P56524 1/20 0.44
GSK3A P49840 3/20 0.44
GSK3B P49841 3/20 0.44
CLK2 P49760 2/20 0.44
CSNK2A1 P68400 2/20 0.44
STK3 Q13188 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29862739 1.00 ALDH1A1 (0.47) ALDH1A1IDH1IDH2NPC1MAPT
SCHEMBL28833987 0.94 USP30 (0.48) IDH1PIM1PIM2HDAC4PARP1
SCHEMBL29933501 0.94 USP30 (0.48) IDH1PIM1PIM2HDAC4PARP1
SCHEMBL28833986 0.94 USP30 (0.48) IDH1PIM1PIM2HDAC4PARP1
SCHEMBL28833998 0.94 USP30 (0.48) IDH1PIM1PIM2HDAC4PARP1
SCHEMBL29933518 0.94 USP30 (0.48) IDH1PIM1PIM2HDAC4PARP1
SCHEMBL23360027 0.92 ALDH1A1 (0.47) ALDH1A1IDH1IDH2NPC1MAPT
SCHEMBL23360460 0.89 GPR119 (0.51) ALDH1A1IDH1IDH2NPC1MAPT
SCHEMBL29863307 0.89 GPR119 (0.51) ALDH1A1IDH1IDH2NPC1MAPT
SCHEMBL23360170 0.88 ALDH1A1 (0.49) ALDH1A1NPC1MAPTMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4055014-B1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORP (KR) 2025-04-30 EP disclosed
US-11655235-B2 Pyrrolidine and piperidine compounds YUHAN CORPORATION (KR) 2023-05-23 US disclosed
EP-4055014-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS Yuhan Corporation (KR) 2022-09-14 EP disclosed
CN-114867719-A Pyrrolidine and piperidine compounds 柳韩洋行 2022-08-05 CN disclosed
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORPORATION (KR) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655235-B2 Pyrrolidine and piperidine compounds FAP, APC, VHL ALDH1A1 439/4885IDH1 943/4885IDH2 1362/4885
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS FAP, APC, VHL ALDH1A1 439/4885IDH1 943/4885IDH2 1362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.